Abstract: The mechanism(s) of volatile anesthetics (VAs) are poorly understood. High-resolution NMR spectroscopy was used to determine the structure of the halothane- 
INTRODUCTION
Volatile anesthetic (VA) drugs are used extensively with little knowledge of their cellular targets or mechanisms. The targets likely include proteins because anesthetic effects ultimately manifest as changes in protein function. This is further supported by the observation that the bioluminescent protein luciferase is inhibited in vitro by direct interaction with a variety of anesthetic agents. 1 Calmodulin (CaM) is a ubiquitous Ca 2+ second messenger that regulates many anesthetic sensitive systems. CaM has two EF hands, Ca 2+ -binding domains that can bind up to 2 Ca 2+ ions each. The EF hands are located at the N-and C-termini and are separated by a flexible central helix. The main difference between calcium-free CaM (apoCaM) and [Ca 2+ ] 4 -CaM is the interhelical angle HALOTHANE BINDING TO CAM 1657 and labeling efficiency (96 %) were verified by ESI-MS by direct infusion. Smooth muscle myosin light chain kinase (smMLCK) isoform 5 was prepared as previously described. 14 Human MLC cDNA was sub-cloned into pET-15b expression vector (Novagen, San Diego, CA) using standard cloning techniques. MLC was overexpressed in BL21(DE3)-pLysS strain of E. coli (Single Shot, Novagen, San Diego, CA). The regulatory light chain (AL050318) was amplified from dT-primed cDNA derived from human lens epithelial cells using Fusion polymerase from New England Bio Labs. The primers used for amplification were Nde1 forward gccatatgtccagcaagcgggccaa and Spe1 reverse gaactagtctagtcgtctttatccttggcgcc. The amplified cDNA was cloned into a pET 15 B vector containing an N-terminal his tag linearized with Nde1 and Spe1 using standard cloning techniques. Recombinant clones were sequence verified. Protein expression was performed using Magic Media (Invitrogen). Briefly, an isolated clone was grown overnight in 50 ml Magic Media. The cells were pelleted by centrifugation at 5000g and lysed in Bug Buster media (Novagen). The inclusion bodies were collected by centrifugation and resuspended in 50 mM Tris-HCl (pH 8), 7 M urea, 250 mM NaCl, and 1 mM 2-mercaptoethanol. The solution was passed over a Ni-NTA column equilibrated in the same buffer. The protein was refolded on the column using a urea gradient (8 to 0 M) flowing at 0.2 ml min -1 for 16 h. The protein was eluted using a buffer containing 50 % glycerol, 50 mM Tris-HCl (pH 8), 250 mM imidazole, and 1 mM 2-mercaptoethanol. The MLC was judged greater than 90 % pure by SDS-PAGE with Coomassie Brilliant Blue staining.
The skeletal myosin light chain kinase peptide recognition sequence (skMLCKp) (biotin-CAAARWKKNFIAVSAANRFKKIS) was synthesized by Genetech, inc. (San Antonio, TX).
Lactate dehydrogenase, pyruvate kinase, phosphoenolpyruvate (PEP), NADH, and ATP were purchased from Sigma (St. Louis, MO).
NMR spectroscopy
Samples of 2mM [ 13 C, 15 2), 20 mM CaCl 2 , 5 mM MgCl, 1 mM EDTA, were equilibrated with halothane to various mole ratios. It was possible to achieve up to about 1:70 CaM:halothane ratio, as determined by proton NMR. For structure determination the samples with 1:10 CaM:halothane ratio were used. Preparation of samples in the oriented media, for measurements of residual dipolar coupling (RDC), failed because of interference with halothane. It was found that the phage media coagulated upon halothane addition, and gel media gave a prohibitory fast relaxation in the presence of halothane. NMR experiments were performed at 25 °C on a 700 MHz spectrometer (Bruker Avance 700) equipped with a cryo-probe. Backbone and side-chain assignments were obtained using a combination of standard triple resonance experiments. 15 2D HNHA, 3D HNCO, HNCA, HN(CO)CA, HNCACB and CBCA(CO)NH were used for the 1 H, 15 N and 13 C assignments of the protein backbone. Side-chains 1 H and 13 C assignments of the non-aromatic side chains were obtained using 3D HAHB(CO)NH, (H)CC(CO)NH, HCCH-COSY and HCCH-TOCSY spectra. Assignments were crosschecked for consistency with 3D 15 N-edited and 13 C-edited [ 1 H, 1 H]-NOESY spectra. The 1 H and 13 C spin systems of the aromatic side-chains where identified using 3D HCCH-COSY and HCCH-TOCSY spectra, while the sequential assignment was based on NOE connectivity in the 13 C-edited [ 1 H, 1 H]-NOESY spectrum. Methionine methyl-group 1 H and 13 C assignment was achieved using methionine-methyl 13 C ε -filtered [ 1 H-13 C]-HSQC spectrum and 13 C γ,ε -filtered [ 1 H-13 C]--HMBC spectrum. 15 NOESY spectra for structural constraints were recorded at mixing times of 50 ms, 100 ms and 150 ms. Quantitative J-correlation HNHA experiment 15 was used for measurement of 3 J(H N H α ) couplings. The 1 H-15 N heteronuclear NOEs 16 were recorded using a 500 MHz spectrometer (Bruker Avance 500). The multidimensional spectra were processed and analyzed in FELIX (Felix NMR, 2007) . All analyses performed after peak picking (assignments and structural parameter calculations) were realized using custom programs in MATLAB (The MathWorks, 2007). About 1600 NOE distances (including 19 halothaneprotein distances) where extracted (see Table I 4 -CaM were also enforced by the distance constraints. Additional distance constraints were defined to maintain coordination geometry around Ca 2+ .
Structure calculations
The initial conformation of the [Ca 2+ ] 4 -CaM N-terminus lobe (residues 1-76) or C-terminus lobe (82-148) was set to the most representative conformer of the reported NMR solution structure of [Ca 2+ ] 4 -CaM, 1J7O.pdb or 1J7P.pdb, respectively. 17 Halothane was positioned ≈5 Å above the hydrophobic pocket of each terminus. QUANTA/XPLOR 18 was used for structure calculations: standard simulated annealing schedule, refinement by cooling and energy minimization with distance and dihedral restraints. The final structures were not sensitive to the initial positioning of halothane. Of the 50 structures produced (for each lobe), about 15 were within 10 % of the lowest energy structure. These low-energy structures were subjected to a short (100 steps steepest descend) energy minimization in the CHARMm22 force-field (Molecular Simulations Inc., 1994), without any restraints except that Ca 2+ coordination geometry was kept fixed. Five structures (for each lobe) that fully complied with the constraints were selected in the final set.
Data deposition
The NMR constraints and atomic coordinates for the conformers were deposited at Protein Data Bank (PDB entries 2kug and 2kuh for N-and C-terminus lobes, respectively).
[Ca 2+ ] 4 -CaM-skMLCKp binding
Binding was determined from the change in emission of the tryptophan residue in the skMLCKp peptide measured in a stirred narrow channel 1 cm fluorescence cuvette (Helman) using a Fluoromax-3 instrument (Jobin-Yvon-Spex). The excitation wavelength was 280 nm, the emission wavelength was 333 nm, the excitation and emission slit widths were 5 nm, and the integrated emission intensity was averaged from thirty 1 s scans. The assay buffer was 50 mM MOPS (pH 7.3), 100 mM KCl, 1 mM MgCl 2 and 0.1 mM CaCl 2 . The solutions were filtered and centrifuged to remove light scattering interferants. A set of titration data were collected in the following order: the background emission from the buffer was measured first. Then 2.7 nM skMLCKp was added into the cuvette and the emission was remeasured. This solution was discarded and a fresh volume of buffer was added to a clean cuvette and the emission measured. Then [Ca 2+ ] 4 -CaM was added to a concentration of 1.3 nM and the emission recorded. Finally, skMLCKp peptide was added to a concentration of 2.7 nM and the emission was recorded. The solution was discarded and the series of measurements was repeated for 2. The data fitting was realized using Origin 7.5 (OriginLab) and the parameters are reported as mean ± sd of the fits to the three-titration data sets.
[Ca 2+ ] 4 -CaM-smMLCK activity
The [Ca 2+ ] 4 -CaM-dependence of the smMLCK activity was measured using a spectroscopic method coupled to pyruvate kinase and lactate dehydrogenase, 19 which was modified to work in a 96-well format fluorescence plate reader. Briefly, when smMLCK transfers a phosphate group from ATP to MLC, it produces a molecule of ADP. Pyruvate kinase (PK) acts on ADP and phosphoenolpyruvate (PEP) to produce ATP and pyruvate. Lactate dehydrogenase (LDH) acts on pyruvate and NADH to produce NAD + and lactate. Thus, for each MLC phosphorylated, one molecule of the fluorescent NADH is converted to the non-fluorescent NAD + . The specific activity of smMLCK was determined by recording the kinetics of NADH disappearance using a Fluostar Optima Fluorescence plate reader (BMG) with 350 and 460 nm excitation and emission filters, respectively. The kinetic assays were performed in triplicate on 200 μl samples. A typical well contained 20 mM MOPS (pH 7.5), 100 mM KCl, 0.1 mM EGTA, 1.5 mM dithiothreitol (DTT), 1.2 mM PEP, 10 μM NADH, 4.3 units of LDH/PK, 20 μM regulatory light chain (RLC), 100 ηg MLCK, and various amounts of [Ca 2+ ] 4 -CaM. The maximum fluorescence intensity of the NADH in the wells was recorded prior to initiating the assay by automatically injecting 10 μl of a solution containing 6 mM ATP, 40 mM MgCl 2 , and 10 mM CaCl 2 , which dilute to a final concentration of 0.3 mM ATP, 2 mM MgCl 2 , and 0.5 mM CaCl 2 in the wells. The time dependent decrease in NADH fluorescence was recorded at 30 s intervals for approximately 10 min, after which the reaction was stopped by automatically injecting 10 l of 400 M ADP (20 M final concentration) into each well. The baseline fluorescence intensity of the NADH-depleted samples was then recorded.
RESULTS

Solution structure of [Ca 2+ ] 4 -CaM-halothane complex
The aim was to determine the structure of the [Ca 2+ ] 4 -CaM-halothane complex at low halothane concentrations, because physiological concentrations of a VA in anesthesia are rather low. The titration with halothane was followed by (Fig. 1, bottom) . The most pronounced differences were in the N-terminus. There were no significant differences in the region of the central linker (residues 77-82). The regional mobility of the complex, as probed by backbone { 1 H-15 N}-NOE (Fig. 1, top) in the C-terminus lobe. The best quality NOE contacts were seen for the methyl groups of methionines because of their favorable relaxation properties (Fig. 2) . Numerous intra-calmodulin NOE contacts (≈800 per lobe) were all in support of the lobe structures as found in the NMR solution structure of [Ca 2+ ] 4 -CaM. 17 Calculated methyl-halothane distances are shown.
The structure of the complex was solved under the assumption that halothane binding has a minor effect on the protein fold, which was justified by the similarity of the chemical shifts in [Ca 2+ ] 4 -CaM determined with and without halothane, by the NOE contacts, and the 3 J(H N H α ) couplings. Thus, the protein dihedral angles (ψ, φ and χ 1 ) were constrained to those of free [Ca 2+ ] 4 -CaM except in the regions of more pronounced (> 0.5 ppm) chemical shift differences (Fig. 1, bottom) . Due to the flexible disposition of the two CaM lobes, the NMR solution structure was solved separately for the N-terminus and for the C-terminus lobes. The final structures were similar to the uncomplexed [Ca 2+ ] 4 
-CaM
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Available online at www.shd.org.rs/JSCS/ structure 17 having an average deviation between the backbone or side-chains of ≈2 Å and ≈3 Å, respectively. The structural statistics are given in Table I .
The obtained structures (Fig. 3) show halothane binding in the region of the hydrophobic pockets, which are binding targets for many other ligands. 21 The N-terminus lobe structural models show a deeper imbedding of halothane than in the C-terminus, as could have been expected from the induced chemical shift changes of CaM (see above, Fig. 1, bottom) . The orientation of the halothane varies considerably in the models, because there are no empirical constraints on the trifluoromethyl half of the molecule. An attempt was made to obtain additional constraints by measuring the 1 H-19 F dipolar couplings in oriented media, but halothane was found to disrupt the properties of the orientation media, i.e., phage and co-solvents. 4 
-CaM binding
The emission spectrum of the skMLCKp peptide excited at 280 nm was measured and it was found that the peak increased in intensity and was blueshifted upon binding to [Ca 2+ ] 4 -CaM (Fig. 4, top panel) . This result is consistent with previous. 22 The most significant difference between the spectra of the bound and unbound peptide was observed at 333 nm. The emission of the peptide at 333 nm at various [Ca 2+ ] 4 -CaM concentrations up to 16 nM was measured (Fig. 4, bottom panel) . The binding curves yielded a mean K d of 1.3±0.4 nM, which agrees with the K d value of 4 nM determined previously using surface plasmon resonance. 23 Moreover, 10 mM isoflurane did not significantly affect the fluorescence intensity of skMLCKp in the presence of 2.7 nM [Ca 2+ ] 4 -CaM. 
smMLCK activity
The specific activity of smMLCK was determined using an ADP/NADH coupled assay. Representative spectra recorded in the presence of various concentrations of [Ca 2+ ] 4 -CaM up to 300 nM illustrate the assay (Fig. 5, top panel) . The initial plateau is the maximal emission from NADH, determined prior to initiating the assay. The drop in intensity (≈10 %) that occurred when a solution of ATP, MgCl 2 , and CaCl 2 was automatically injected to start the reaction was due to minor ADP contamination. This was followed by a steady decrease in 1664 JURANIĆ et al.
NADH fluorescence that was dependent on the [Ca 2+ ] 4 -CaM concentration. The rate of fluorescence decrease was directly proportional to the phosphorylation of the myosin light chain. The final steep drop occurred when an ADP solution was automatically injected, which consumes the remaining NADH. The end plateau was the signal from the sample without NADH. The difference between the plateaus at the beginning and end of the assay was used to calibrate the instrument response to the amount of NADH present. The error bars represent the standard deviation in the mean of thirty, 1 s fluorescence measurements. The solid line was generated using the mean parameters from the curve fits to the three sets of titration data. It was found that 10 mM isoflurane did not significantly affect the fluorescence intensity of skMLCKp in the presence of 2.7 nM [Ca 2+ ] 4 -CaM (closed stars).
The specific activities of the smMLCK, calculated from the slopes are plotted as a function of [Ca 2+ ] 4 -CaM concentration in Fig. 5 , bottom panel. The maximum activity of smMLCK in the presence of [Ca 2+ ] 4 -CaM was found to be approximately 12 μmol min -1 mg MLCK -1 , which is consistent with previous results. 19 The effect of various concentrations of halothane on the activity of MLCK alone and in the presence of [Ca 2+ ] 4 -CaM at concentrations that produce half-maximal (2 nM) and maximal (100 nM) activation was measured. Halothane was found to inhibit the MLCK activity, but it was not [Ca 2+ ] 4 -CaM dependent (Fig. 6) . interacts with methyl groups, primarily from methionine residues, whereas W-7 also interacts with complementary aromatic groups at the base of the pockets. This preferential interaction with methyl groups is likely supported by their high concentration at the pockets entry. In a more dominant aromatic environment, halothane could also engage aromatic groups. 25 The lack of halothane penetration into the C-terminal pocket is particularly significant because that is where the tryptophan side chains (i.e., Trp-4 of the CaM-binding peptide from the MLCK, 24 or Trp-8 of the CaM-binding peptide 26, 27 4 -CaM by triangulation to three residues at the bottom of the pockets that are iso-topical in the N-and C-terminuses was made (Scheme 1 and Table II ). The data in the last two columns of Table II verify that ligand penetration depth into the C-terminus hydrophobic pocket is crucial for the onset of antagonist behavior. The finding that halothane interacts with methyl groups in [Ca 2+ ] 4 -CaM is consistent with previous observations that VAs contact primarily aliphatic residues in serum albumin 28 and interact solely with the choline methyl groups in dipalmitoylphosphatidylcholine vesicles. 29 This appears to be a general feature of VAs-protein interactions, which were used as criteria to identify amphiphilic pockets in protein structures where VAs bind. 10, 11 This finding is consistent with the possibility that protein methyl groups act as weak hydrogen bond donors to the methyl halogens, namely fluorine, found in VAs. 30 However, this is only speculation because data necessary for the determination of the orientation of halothane relative to the methyl groups of [Ca 2+ ] 4 -CaM is lacking. 31 This was unexpected since halothane was shown to reduce the amount of synaptic PDZ domain-mediated protein interactions with NMDA receptor and nNOS without significantly altering the K d value. 32 It is possible that VAs behave like the [Ca 2+ ] 4 -CaM antagonist TFP and alter the on-rate of the MLCK peptide, but not the steady state amount of complex formed. 31 However, a reduction in the on-rate would increase the steady state K d and right-shift the binding curve. This was not the case since isoflurane had no effect on the intensity observed near the half-maximal [Ca 2+ ] 4 -CaM. These results indicate that VAs do not significantly antagonize the interaction of [Ca 2+ ] 4 -CaM with skMLCKp.
Halothane inhibits smMLCK activity
The kinetic fluorescence assay indicated that the MLCK activity is inhibited in a concentration-dependent manner by halothane. Fluorescence quenching by halothane does not present a problem for this assay because the instrument response is calibrated using the NADH fluorescence from each sample condition. It was found that MLCK is inhibited by VAs in the absence of [Ca 2+ ] 4 -CaM and in the presence of sub-maximal and maximal concentrations of [Ca 2+ ] 4 -CaM. This indicates that the mechanism by which halothane inhibits MLCK is independent of [Ca 2+ ] 4 -CaM, which is consistent with the finding that isoflurane does not inhibit [Ca 2+ ] 4 -CaM binding to skMLCKp.
